Patient Registry Software Market Report 2026

Patient Registry Software Market Overview

• Patient Registry Software market size has reached to $2.8 billion in 2025 • Expected to grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 16% • Growth Driver: Electronic Medical Records Fueling The Patient Registry Software Market A Path To Enhanced Healthcare Management • Market Trend: Innovative Contact Registries Transforming The Patient Registry Software Market Advancing Rare Disease Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Patient Registry Software Market?

Patient registry software refers to digital platforms designed to collect, store, and manage comprehensive patient data related to specific diseases, conditions, treatments, or populations. It is used for tracking clinical outcomes, supporting research, improving care coordination, and enabling data-driven decision-making in healthcare settings. The main types of products in patient registry software are integrated software and standalone software. The various types of databases are disease registries, health service registries, and product registries. The disease registry is used in the state of a particular disease or condition as the inclusion criterion. A disease registry refers to a unique database that includes data on people who have been diagnosed with a certain disease type. The different deployment models include on-premise and cloud-based that involve several functionalities such as population health management, patient care management, medical research and clinical studies, health information exchange, point-of-care, and product outcome evaluation. It is employed by government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, and research centers.

What Is The Patient Registry Software Market Growth Forecast?

The patient registry software market size is expected to see rapid growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing use of predictive analytics for patient outcomes, rising demand for cloud-based registries, growing emphasis on real-time population health management, expansion of integrated ehr and registry solutions, rising utilization of registries for clinical trials and research. Major trends in the forecast period include increasing adoption of ai-driven patient data analytics, rising deployment of cloud-based patient registries, growing integration of ehr and pms with registry software, increasing focus on real-time population health monitoring, rising utilization of data for clinical research and outcomes.

Global Patient Registry Software Market Segmentation

1) By Product: Standalone Software, Integrated Software 2) By Type Of Database: Disease Registries, Health Service Registries, Product Registries 3) By Deployment Model: On-Premise Models, Cloud-Based Models 4) By Functionality: Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE), Point Of Care, Product Outcome Evaluation, Medical Research And Clinical Studies 5) By End User: Government Organizations And Third-Party Administrators, Hospitals And Medical Practices, Private Payers, Pharmaceutical, Biotechnology, And Medical Device Companies, Research Centers Subsegments: 1) By Standalone Software: Disease-Specific Registries, Patient-Centered Registries, Research Registries, Population Health Registries 2) By Integrated Software: Electronic Health Record (EHR) Integrated Software, Practice Management System (PMS) Integrated Software, Clinical Decision Support System (CDSS) Integrated Software, Health Information Exchange (HIE) Integrated Software

What Is The Driver Of The Patient Registry Software Market?

The rising adoption of electronic medical records (EMRs) is contributing to the growth of the patient registry software market going forward. An electronic medical record is a digital counterpart of a patient's paper chart. An EMR can help with billing, inter-practice referrals, appointment scheduling, and medication refills. The patient registry software functionality is included as an add-on in EMR and EHR products, thereby promoting the patient registry software market. For instance, in October 2024, according to the NHS England, a UK-based public sector executive non-departmental body of the UK government, reported that in November 2023, NHS England achieved the previous government’s target of 90% of trusts adopting Electronic Patient Records (EPR) systems, granting authorized clinicians access to crucial patient information. Therefore, the rising adoption of electronic medical records will drive the growth of the patient registry software industry.

Key Players In The Global Patient Registry Software Market

Major companies operating in the patient registry software market are Armus Digital Pvt. Ltd., Dacima Software Inc., Evado Clinical, Global Vision Technology Co. Ltd., Gz Technology Pvt. Ltd., Healthmonix LLC, Imagetrend Inc., QVIA Holdings Inc., Lumedx Healthcare Technologies Private Limited, M2s Industries Private Limited, Mckesson Corporation, Opentext Corporation, Optum Health & Technology Private Limited, Phytel Inc., Premier Inc., Syneos Health Inc., Telligen Inc., Advarra Inc., Advera Health Analytics, ArborMetrix Inc., EResearch Technology, FIGmd Inc., Flatiron Health Inc., Healex Systems Ltd., IFA Systems AG, Liaison Technologies Inc., Medrio Inc., Molecular Corp., OM1 Inc., Open Registry, Orion Health Corp.

Global Patient Registry Software Market Trends and Insights

Major companies operating in the patient registry software market are focusing on developing innovative products, such as contact registries, to better meet the needs of their existing consumers. A contact registry is an inventory or system that gathers and stores contact details for a particular group of individuals. Contact registries are operated for a variety of reasons, including emergency management, clinical trial patient recruitment, and disease surveillance. For instance, in November 2025, the National Organization for Rare Disorders (NORD), a U.S.-based non-profit organization supporting rare-disease research, advocacy, and patient registries, launched a request for proposals (RFP) to establish new patient registries on its IAMRARE® platform. This registry initiative is intended to connect patients with rare diseases to researchers and facilitate engagement in research studies. The registries will collect and securely store contact details of individuals who wish to receive updates about rare-disease research and will also inform participants about available research opportunities and studies. These registries are managed by NORD in collaboration with patient-advocacy organizations, providing infrastructure, training, data management, and governance oversight to ensure long-term registry sustainability.

What Are Latest Mergers And Acquisitions In The Patient Registry Software Market?

In October 2023, Access Healthcare an India-based revenue cycle management (RCM) and healthcare services company acquired Envera Health for an undisclosed amount. By integrating Envera's patient engagement capabilities through this acquisition, Access Healthcare will enhance its end-to-end RCM service delivery and further improve its proprietary workflows and process intelligence platform. Envera Health is a US-based human + tech engagement services company that delivers an ecosystem of connectivity to strengthen health systems and physician practices.

Regional Outlook

North America was the largest region in the patient registry software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Patient Registry Software Market?

The patient registry software market consists of sales of software and services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Patient Registry Software Market Report 2026?

The patient registry software market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the patient registry software industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.